Processing your request


please wait...

Case Page

 

Case Status:    DISMISSED    
On or around 03/25/2020 (Other)

Filing Date: January 27, 2020

According to the Complaint, Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions.

This action stems from a proposed transaction announced on January 10, 2020, pursuant to which Dermira, Inc. will be acquired by Eli Lilly and Company.

On January 10, 2020, Dermira’s Board of Directors caused the Company to enter into an agreement and plan of merger with Eli Lilly. Pursuant to the terms of the Merger Agreement, Merger Sub commenced a tender offer to purchase all of Dermira’s outstanding common stock for $18.75 per share in cash. The Tender Offer is set to expire on February 19, 2020.

On January 22, 2020, Defendants filed a Solicitation/Recommendation Statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Solicitation Statement omits material information with respect to the Proposed Transaction, which renders the Solicitation Statement false and misleading.

This case was voluntarily dismissed on March 24, 2020.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: DERM
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 20-CV-00132
JUDGE: Hon. Maryellen Noreika
DATE FILED: 01/27/2020
CLASS PERIOD START: 01/10/2020
CLASS PERIOD END: 01/27/2020
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Rigrodsky & Long, P.A. (Wilmington)
  2. RM Law, P.C. (Berwyn)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available